← FDA Drug Approvals (Drugs@FDA)

NITROFURANTOIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ANNORA PHARMA · Approved 2025-07-02

Drug application

FDA Application #

ANDA219495

Application type

Abbreviated New Drug Application (Generic)

Brand name

NITROFURANTOIN

Generic name

NITROFURANTOIN

Active ingredients

NITROFURANTOIN

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

ANNORA PHARMA

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2025-07-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown